Skip to product information
1 of 2

Rathdrum Total Body Wellness

Wolverine (BPC+TB) Therapy

Wolverine (BPC+TB) Therapy

Regular price $0.00 USD
Regular price Sale price $0.00 USD
Sale Sold out
Strength
Quantity

Wolverine (BPC-157 + TB-500)

1.6mg/1.6mg/ml 3mls (5mg + 5mg vial) $117 [10-20 Injections]

3.3mg/3.3mg/ml 3mls (10mg + 10mg vial) $147 [20-42 Injections]

10mg/10mg/ml 3mls (30mg + 30mg vial) $227 [60-150 Injections]

Tissue Repair | Muscle & Joint Recovery | Inflammation Research | Connective Tissue Health

What Is Wolverine?

Wolverine is a combination of two investigational peptides, BPC-157 and TB-500, both of which have attracted research interest for their potential roles in tissue repair, inflammation regulation, and recovery.

BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids. It has been studied primarily in preclinical research involving tissue healing, gastrointestinal protection, and musculoskeletal injuries.

TB-500 is a synthetic peptide associated with thymosin beta-4, a naturally occurring protein involved in cellular movement and tissue maintenance. Research involving thymosin beta-4-related pathways has explored wound healing, inflammation, and tissue remodeling.

Together, these peptides are being investigated for their potential complementary effects on the biological processes involved in tissue maintenance and recovery.

Areas of Research & Potential Benefits

Tissue Repair & Regeneration

Both peptides have attracted interest for their involvement in pathways associated with cellular repair, tissue remodeling, and healing following injury.

Muscle Recovery & Repair

Preclinical research involving BPC-157 and thymosin beta-4-related pathways has explored muscle tissue recovery, cellular repair, and responses to muscle injury.

Tendon & Ligament Health

BPC-157 has been investigated in animal models of tendon and ligament injuries, while thymosin beta-4 research has explored cellular migration and connective tissue remodeling.

These areas of research have generated interest in the combination's potential applications involving connective tissue health.

Inflammation Regulation

Both peptides have been investigated for their influence on inflammatory signaling pathways and the body's response to tissue damage.

Joint Health & Mobility

Research involving muscle, tendon, and ligament repair has contributed to interest in these peptides for joint-related structures and the biological processes that support normal movement.

Blood Vessel Formation & Circulation

BPC-157 and thymosin beta-4-related research has explored angiogenesis, the process through which new blood vessels form. This process contributes to oxygen and nutrient delivery during tissue healing.

Skin & Wound Healing

Research involving thymosin beta-4 has explored skin repair, cellular migration, and wound closure. BPC-157 has also been investigated in preclinical models involving tissue injury and healing.

Who Should Avoid Wolverine?

Wolverine contains investigational peptides and should not be used outside an appropriately authorized clinical research setting.

Particular concerns apply to:

  • Pregnant or breastfeeding individuals: Safety has not been established.
  • Children and adolescents: Effects on growth and development have not been adequately evaluated.
  • Individuals with active cancer or a history of cancer: The peptides' potential influence on cellular activity and blood vessel formation warrants caution.
  • Individuals with significant liver or kidney disease: Safety has not been established in these populations.
  • Individuals with known allergies to peptide formulations: Allergic or immune reactions may occur.

Potential Side Effects

The complete side-effect profile of this combination has not been established.

Potential concerns associated with injectable peptide formulations include:

  • Injection-site redness, swelling, or irritation
  • Allergic or immune reactions
  • Local inflammatory responses
  • Reactions associated with impurities or formulation ingredients

Important Information

Wolverine (BPC-157 + TB-500) is an investigational peptide combination and is not FDA-approved for tissue repair, muscle recovery, inflammation, joint health, or any other medical indication.

The FDA has identified potential safety concerns involving BPC-157 and TB-500, including immunogenicity and peptide-related impurities.

Ordering Information

Please note: You will not be charged for the peptide when checking out through our website.

Once your order has been submitted, you will receive a follow-up email with additional information regarding the peptide, the consultation process, and the next steps.

All requests are subject to appropriate medical review and applicable prescribing requirements. Submitting an order does not guarantee approval or fulfillment.

View full details